Multi-Scale Analysis of Phenotypes in Heart Failure (MAP-HEART) | MicrobiomeTrials← Back to trialsNCT06280820
Multi-Scale Analysis of Phenotypes in Heart Failure (MAP-HEART)
ENROLLING_BY_INVITATIONOBSERVATIONAL
Trial Details
Start: 2026-06-15Est. Completion: 2028-04-30
Enrollment target: 2,000 participants Locations- INOVA Fairfax Hospital, Falls Church, Virginia, United States
Other microbiome trials you might be interested in
Mitral Valve ProlapseMitral Regurgitation
Mitral regurgitation (MR) is the second most frequent valvular heart disease and the second most frequent indication for…
Milan, ItalyEst. completion Jun 1, 2029
Heart FailureNYHA Class III Heart FailureNYHA Class II Heart Failure
This is an international, multi-center, prospective, randomized, open-label blinded endpoint study designed to demonstra…
Tulsa, United StatesEst. completion Aug 2029
Phase 1
Recruiting
SARS-CoV-2Influenza, HumanRespiratory Syncytial Virus InfectionsRespiratory Distress SyndromeSystemic Inflammatory Response Syndrome
The purpose of this clinical trial is to evaluate the safety, tolerability and efficacy of two doses (dose A and dose B)…
Alcalá de Henares, SpainEst. completion Oct 2, 2026